Flow Cytometry Market will Reach $6.5 Billion Globally by 2020 with Increasing Precision - Allied Market Research

Flow Cytometry Market will Reach $6.5 Billion Globally by 2020 with Increasing
                      Precision - Allied Market Research

  PR Newswire

  PORTLAND, Oregon, December 19, 2013

PORTLAND, Oregon, December 19, 2013 /PRNewswire/ --

Allied Market Research today published a new market research report titled
"Flow Cytometry Market (Products, Application, Technology, and Users) -
Current Trends, Opportunities, Industry Analysis, Size, Share and Global
Forecast, 2012-2020". As per the study, the flow cytometry market valued $3
billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a
CAGR of 30.9%. Increasing needs to enhance precisions and produce faster
results as well as need for compact devices are compelling the clinical and
diagnostic organization to adopt innovative technologies. Though popularity
has been gained in the application field of life science industry, the cost of
the instrument is impeding the growth. Due to this, many researchers are still
reluctant in adopting this technology in their research work. Moreover,
advancing technologies that has brought complex instrumentation requires
highly skilled personals to operate these instruments.

The complete report is available at
http://www.alliedmarketresearch.com/flow-cytometry-market

"Flow cytometry market is in developing phase. Enhancing precision in results
and presence of numerous flow cytometry techniques such as multicolor and
multi-parameter flow cytometry has acted as a strong foothold, assisting the
market growth in majority of the developed economies and foresees high
potential in the emerging economies such as Asia Pacific and Africa. These
economies have high demand for better health care techniques at an affordable
cost. Increasing aged population who need better healthcare, increase in
chronic disease and need for better diagnosis and treatment are few driving
factors that are impacting the flow cytometry market" state AMR analysts
Debbie Shields and Rohini Patil.

Immunotyping and signal transduction, for example, have been playing a
significant role in medical diagnostics. However, conventional technologies
used, have limited the accuracy and impacted the result deliverance time of
the diagnosis performed. Improving therapeutic scenario is equally attracting
focus on early diagnostic tools. Currently, many cancer types have various
treatment options; however, this depends on the time of diagnosis and the
stage of the cancer. Flow cytometry has been one of the most prevalent
technologies which offer solutions for most of the problems discussed above.
Key factors restraining the market include high instrument costs and size,
lack of awareness among probable users and need for trained personnel. Most of
the users are not aware of the advanced development in the flow cytometry
technology and believe that the instruments are space consuming, complex in
use and are of high cost, thus affecting the market growth.

Browse all diagnostics and biotech reports at
http://www.alliedmarketresearch.com/diagnostic-and-biotech-market-report

The global market for flow cytometry is divided into segments such as
products, technology, end users, and applications. Instruments market accounts
for the largest share of revenue in the flow cytometry market at present and
is expected to remain as the highest revenue generator in 2020. Increase in
modularity, accessibility, incorporation of imaging capabilities, availability
of wavelengths and targets and size reduction are few of the significant
trends in the market assisting in adoption of the instruments by the end
users. On the other hand, reagents market is expected to experience the
highest growth rate of CAGR 12% during the analysis period. Primary reason
escalating this segment is availability of several types of reagents that find
diverse usability depending on specific applications like diagnostics, drug
discovery, etc.

Few similar studies by Allied Market Research

Biomarkers Market: http://www.alliedmarketresearch.com/biomarkers-market

Biomaterials Market: http://www.alliedmarketresearch.com/biomaterials-market

Two technologies are implemented in flow cytometry based research and
diagnosis, namely cell based and bead based technologies. In the present
scenario as well as throughout the analysis period, cell based technique is
leading the market in terms of revenue generation. However, bead based
technique is expected to beat this technology in terms of adoption rate by
2020.

North America accounted for the largest share of revenue i.e. 43.5% of the
overall Global flow cytometry market at $1.2 billion in 2011. The region is
further expected to attain a market size of $2.8 billion by 2020 growing at a
CAGR of 10.1%. The company profile in this includes: Advanced analytical
Technologies, Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter,
eBioscience, Partech, Life technologies corp., Luminex Corp, Amnis Corp.,
Morphosys AG. The primary strategy employed by key players of the market is
products launch which is due to demand for newer, faster, and high through put
machines that deliver better results.

About Us:

Allied Market Research (AMR) is a full-service market research and business
consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied
Market Research provides global enterprises as well as medium and small
businesses with unmatched quality of "Market Research Reports" and "Business
Intelligence Solutions". AMR has a targeted view to provide business insights
and consulting to assist its clients to make strategic business decisions and
achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this
helps us in capturing most accurate market data and confirms utmost accuracy
of our market forecasts. Each and every data presented in the reports
published by us is also extracted through primary interviews with top
officials from leading companies of domain concerned. Our secondary data
procurement methodology includes deep online and offline research and
discussion with knowledgeable professionals and analysts in the industry.

Contact: Sona Padman 5320 SW Macadam Avenue, Suite 100, Portland, OR
97239United States Direct:  +1-(617)-674-4143 Toll Free: +1-(855)-711-1555
(U.S. & Canada) Fax: +1-(855)-550-5975 Email: sales@alliedmarketresearch.com
Web: http://www.alliedmarketresearch.com
 
Press spacebar to pause and continue. Press esc to stop.